This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Xoma Corporation. Active years: 1999-2003.
Location History:
- Carmel Valley, CA (US) (1999)
- Berkeley, CA (US) (2000 - 2003)
Company Filing History:
Years Active: 1999-2003
Title: The Innovations of Mitchell B. Fadem
Introduction
Mitchell B. Fadem is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-fungal peptides. With a total of 3 patents to his name, Fadem's work has the potential to impact various medical applications.
Latest Patents
Fadem's latest patents focus on anti-fungal peptides derived from Domain III of bactericidal/permeability-increasing protein (BPI). These peptides are designed for both in vivo and in vitro uses, showcasing their versatility in combating fungal infections. The innovative nature of these peptides highlights Fadem's commitment to advancing medical science.
Career Highlights
Mitchell B. Fadem is currently associated with Xoma Corporation, where he continues to push the boundaries of research and development. His work at Xoma Corporation has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of Fadem's notable coworkers include Roger G. Little, II and Edward Lim. Their combined expertise contributes to the innovative environment at Xoma Corporation.
Conclusion
Mitchell B. Fadem's contributions to the field of biotechnology, particularly through his patents on anti-fungal peptides, demonstrate his dedication to innovation. His work not only enhances our understanding of fungal infections but also paves the way for future advancements in medical treatments.